A new study showed that propylthiouracil and methimazole use during pregnancy was associated with increased risk of congenital malformations. Intriguingly, the authors identified dose-dependent effects for methimazole but not propylthiouracil, whereas the recommended switch from methimazole to propylthiouracil during early pregnancy did not reduce the risk of congenital malformations.

Additional Metadata
Persistent URL dx.doi.org/10.1038/s41574-018-0012-6, hdl.handle.net/1765/105933
Journal Nature Reviews Endocrinology
Rights No subscription
Citation
Korevaar, T.I.M, & Peeters, R.P. (2018). Antithyroid drugs and congenital malformations. Nature Reviews Endocrinology, 1–2. doi:10.1038/s41574-018-0012-6